MSD Partners, L.P. - Q2 2013 holdings

$1.83 Billion is the total value of MSD Partners, L.P.'s 42 reported holdings in Q2 2013. The portfolio turnover from Q1 2013 to Q2 2013 was - .

 Value Shares↓ Weighting
No holdings reported for quarter Q2 2013
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2013-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ZIOPHARM ONCOLOGY INC42Q3 202315.7%
JPMORGAN CHASE & CO42Q3 20232.3%
STEALTHGAS INC39Q3 20232.8%
COOPER STD HLDGS INC29Q2 20223.0%
CITIGROUP INC28Q3 20231.4%
NATIONAL GEN HLDGS CORP26Q3 202015.3%
MARTEN TRANS LTD26Q3 20191.1%
SYNTHETIC BIOLOGICS INC21Q2 20180.5%
COTY INC20Q4 20187.4%
BLUEKNIGHT ENERGY PARTNERS L19Q4 20171.7%

View MSD Partners, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)

View MSD Partners, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
40-APP2024-04-11
42024-03-08
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
42023-12-14

View MSD Partners, L.P.'s complete filings history.

Compare quarters

Export MSD Partners, L.P.'s holdings